Dr. Jimenez Jimenez’s area of clinical and research interest is the use of hematopoietic stem cell transplantation (HSCT) and cell therapy for management of high-risk acute leukemias (myeloid and lymphoid) and myelodysplastic syndromes/ myeloproliferative neoplasms ( MDS/MPN). Additionally, he is interested in assessing genetic factors that predict post-transplant relapse and strategies to minimize or manage this complication.